Investment Rating - The investment rating for the company is "Buy" for both A-shares and H-shares, maintained from previous assessments [7]. Core Insights - The company is expected to achieve significant revenue growth in 2025, with projected revenue of 3.25 billion RMB, representing an increase of 89% year-over-year. The net profit attributable to shareholders is forecasted to be 716 million RMB, marking a turnaround from previous losses [2][12]. - The company is advancing its overseas business development (BD) efforts, with expected contributions from key products and partnerships, including a notable deal with AbbVie for RC148, which includes a $650 million upfront payment [3][5]. - The domestic market is showing strong performance, with core products expected to maintain rapid revenue growth due to manageable price reductions in insurance renewals and potential approvals for new indications [2][4]. Revenue and Profit Forecast - Revenue projections for 2025 have been adjusted to 3.25 billion RMB, with a significant increase in net profit to 716 million RMB, reflecting a substantial recovery from previous losses [12][17]. - The company anticipates continued growth in 2026, with revenue expected to reach 7.83 billion RMB, driven by both domestic sales and international BD activities [11][12]. Pipeline Development - The clinical development of RC148 is progressing, with potential for global Phase III trials to start soon, which could enhance its market position significantly [3][4]. - The company is also advancing other key products, including the global Phase III clinical trials for its lead candidates, which are expected to contribute to future revenue growth [4][5]. Valuation and Price Target - The target price for A-shares is set at 151.81 RMB, while the target price for H-shares is 143.58 HKD, reflecting a premium of 18.80% based on recent valuations [5][14]. - The valuation adjustments are based on changes in the fair value of warrants and a decrease in debt financing needs, leading to an updated forecast for net profits in the coming years [12][14].

市场表现 -30 -20 -10 0 10 20 30 40 (%) 芒果超媒 沪深300 资料来源：Wind，华鑫证券研究 2026 年 02 月 02 日 看芒果大模型 AI 赋能主业 小芒电商迎盈利拐点 —芒果超媒（300413.SZ）公司事件点评报告 买入(维持) 事件 分析师：朱珠 S1050521110001 zhuzhu@cfsc.com.cn | 基本数据 | 2026-01-30 | | --- | --- | | 当前股价（元） | 25.47 | | 总市值（亿元） | 476 | | 总股本（百万股） | 1871 | | 流通股本（百万股） | 1022 | | 52 周价格范围（元） | 21.13-35.76 | | 日均成交额（百万元） | 511.71 | 芒果超媒发布 2025 年公司业绩预告公告：2025 年公司归母 净利润 11~14 亿元，同比-19.38%~+2.61%，扣非净利润 8.7~11 亿元（同比-47.11%~-33.12%）。 投资要点 ▌ 2025 年小芒电商迎盈利拐点 芒果 TV 会员 7560 万 内容端，2025 年芒果持续加码优质内容，影视剧 ...

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company is expected to achieve a net profit attributable to shareholders of 135-175 million yuan in 2025, representing a year-on-year decline of 57.1%-66.9%. The non-recurring net profit is projected to be 45-65 million yuan, down 79.6%-85.9% year-on-year [2][4]. - The decline in profits is primarily attributed to increased online traffic costs, upfront expenses related to the new "lifestyle store" format, and significant rises in nut raw material prices, which conflict with the company's "high-end cost-performance" strategy [2][3]. - The company is actively exploring multi-channel strategies and has launched lifestyle stores aimed at creating a "15-minute community convenience living circle," expanding from snacks to a diverse range of products [3]. Financial Summary - Revenue projections for 2025-2027 are 10.87 billion, 12.57 billion, and 13.91 billion yuan, with year-on-year growth rates of +2.3%, +15.7%, and +10.7% respectively. The net profit attributable to shareholders is forecasted at 160 million, 230 million, and 320 million yuan, with year-on-year changes of -59.7%, +41.9%, and +37.4% [4][5]. - The company’s earnings per share (EPS) for 2025 is estimated at 0.41 yuan, with a projected price-to-earnings (P/E) ratio of 58.2 [5][6].

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [4]. Core Insights - The company has established itself as a leader in the pet hygiene care industry, with a steady growth trajectory and a dual-driven model of "export OEM + own brand" [1][14]. - The global pet market is expanding, with significant growth potential in the pet hygiene product segment, particularly in China, where the market is expected to reach 300.2 billion yuan by 2024 [2]. - The company is focusing on both enhancing its production capabilities and expanding its own brand presence domestically, while also integrating its supply chain to drive long-term growth [3]. Summary by Sections Company Overview - The company has over 20 years of experience in the pet hygiene product sector, evolving from a small chemical factory to a leading player in the market [15]. - It operates under a concentrated shareholding structure, with key personnel incentivized to ensure stability and growth [19]. - The main products include disposable pet hygiene products, personal hygiene products, and non-woven fabrics, with a significant focus on pet pads and pet diapers [16][14]. Industry Overview - The pet industry has developed a mature supply chain in developed countries, while China's market is rapidly evolving, driven by changing consumer behaviors and increasing pet ownership [42]. - The demand for pet hygiene products is expected to rise as pet owners adopt more scientific and refined care practices [2]. Growth Outlook - The company is enhancing its production capabilities, with a projected capacity of 4.6 billion pet pads and 200 million pet diapers by mid-2025 [3]. - It is also expanding its global sales channels and focusing on product innovation to meet emerging consumer trends [3]. - The company aims to strengthen its domestic brand presence and integrate its supply chain to explore new growth areas in pet pharmaceuticals, cat litter, food, and smart products [3]. Financial Forecast and Investment Recommendations - Revenue projections for 2025-2027 are estimated at 19.63 billion, 23.30 billion, and 27.10 billion yuan, with corresponding net profits of 2.35 billion, 2.73 billion, and 3.32 billion yuan [4]. - The company is expected to maintain a strong financial position with a low debt ratio and consistent dividend payouts, enhancing its attractiveness to investors [30].

股 票 研 究 继峰股份公告点评 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 刘一鸣(分析师) | 021-23154145 | liuyiming@gtht.com | S0880525040050 | | 房乔华(分析师) | 021-23185699 | fangqiaohua@gtht.com | S0880525040065 | 本报告导读： 继峰股份发布 2025 年业绩预告，预计 2025 年归母净利润 41,000 万元到 49,500 万 元，实现扭亏为盈，我们认为公司在经过多年整合后欧洲经营成本显著下降，同时 乘用车座椅业务规模效应显现，盈利能力大幅增长，公司有望迎来业绩释放的拐点。 投资要点： | [Table_Finance] 财务摘要(百万元) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入 | 21,571 | 22,255 | 23,615 | 27,590 | 3 ...

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company is expected to see gradual improvement in profitability, driven by both internal expansion and brand growth [2] - The company forecasts a net profit attributable to shareholders of between 55 million to 81 million yuan for 2025, representing a year-on-year decline of 80.9% to 71.5% [1][2] - The company is positioned as a core global supplier, with optimistic order prospects for 2026, supported by the ramp-up of overseas production capacity [2] - The brand's transformation into a fashionable accessory is expected to drive significant revenue growth, with a goal for brand revenue to approach manufacturing revenue by 2028 [3] Financial Summary - Total revenue for 2023 is reported at 2,407 million yuan, with projections of 3,332 million yuan for 2024 and 3,278 million yuan for 2025, reflecting a year-on-year growth rate of -0.9%, 38.4%, and -1.6% respectively [4] - The net profit attributable to shareholders is projected to be 250 million yuan in 2023, decreasing to 71 million yuan in 2025, and then recovering to 272 million yuan in 2026 and 386 million yuan in 2027 [4] - The gross profit margin is expected to decline from 31.2% in 2023 to 26.2% in 2025, before stabilizing around 28.1% by 2027 [4] - The projected earnings per share (EPS) for 2025 is 0.15 yuan, with a significant recovery to 0.58 yuan in 2026 and 0.83 yuan in 2027 [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported total revenue and net profit of 2.15 billion and 230 million respectively for 2025, representing a year-on-year increase of 40% and 119% [6] - The Q4 revenue and net profit were 740 million and 110 million respectively, showing a year-on-year decrease of 1% and 48%, but a quarter-on-quarter increase of 60% and a return to profitability [6] - The company benefits from a favorable stock market, leading to steady growth in financial information service revenue and strong cash flow performance [6] - The company has revised down its market trading volume assumptions and adjusted its net profit forecasts for 2026 and 2027 to 360 million and 480 million respectively, with a year-on-year growth of 57% and 34% [6] - The company completed the acquisition and capital increase of Pioneer Fund, holding a 90% stake, enhancing its wealth management ecosystem [6] Financial Performance Summary - In 2025, financial information service revenue was 1.51 billion, up 28% year-on-year, with sales cash inflow of 1.81 billion, up 17% year-on-year [7] - Sales expenses for 2025 were 1.11 billion, up 38% year-on-year, with advertising and online promotion expenses increasing by 67% [7] - The net income from the securities business was 610 million, up 91% year-on-year, with commission income and interest income increasing by 110% and 33% respectively [8] - The company's investment income was 220 million, up 49% year-on-year, with an investment yield of 10%, down from 21.5% in 2024 [8] Financial Projections - Revenue projections for 2026, 2027, and 2028 are 2.74 billion, 3.34 billion, and 3.86 billion respectively, with year-on-year growth rates of 27.7%, 21.8%, and 15.7% [10] - Net profit projections for the same years are 359 million, 481 million, and 580 million, with year-on-year growth rates of 57.4%, 34.0%, and 20.8% [10] - The company maintains a high gross margin, projected to be 92.2% in 2026 and 93.6% in 2028 [10]

计算机/软件开发 指南针（300803.SZ） 2026 年 02 月 01 日 投资评级：买入（维持） | 日期 | 2026/1/30 | | --- | --- | | 当前股价(元) | 124.00 | | 一年最高最低(元) | 179.01/50.40 | | 总市值(亿元) | 756.14 | | 流通市值(亿元) | 750.62 | | 总股本(亿股) | 6.10 | | 流通股本(亿股) | 6.05 | | 近 3 个月换手率(%) | 272.32 | 股价走势图 数据来源：聚源 -50% 0% 50% 100% 150% 200% 2025-02 2025-06 2025-10 指南针 沪深300 相关研究报告 《销售费用环比增长，关注 Q4 高端品 销售情况—指南针 2025 三季报点评》 -2025.10.26 《新增客户数同比高增，下半年订单 弹性可期—指南针 2025 中报点评》 -2025.8.28 《扣非净利润符合预期，业绩和估值 高弹性特征突出—指南针 2025一季报 点评》-2025.4.27 业绩符合预期，证券业务高增体现协同效应 ——指南针 2025 年报点 ...

Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of China Shenhua Energy Company Limited, with a target price of RMB 46.85 per share for A-shares and HKD 45.80 per share for H-shares [6]. Core Views - The 25-year performance forecast is generally in line with expectations, and the acquisition of group assets is progressing smoothly [1]. - The forecast for the 2025 net profit attributable to shareholders is set at RMB 52 billion, reflecting a year-on-year decline of 11.3% to 2.3%, which is better than the non-recurring profit performance [6]. - The company plans to acquire 12 assets from the National Energy Group for a total transaction price of RMB 133.6 billion, which is expected to enhance operational capabilities and profitability [6]. Financial Summary - **Revenue Forecast**: - 2023A: RMB 343,074 million - 2024A: RMB 338,375 million - 2025E: RMB 310,460 million (down 8.2% YoY) - 2026E: RMB 327,292 million (up 5.4% YoY) - 2027E: RMB 338,435 million (up 3.4% YoY) [2][10] - **Net Profit Forecast**: - 2023A: RMB 59,694 million - 2024A: RMB 58,671 million - 2025E: RMB 52,293 million (down 10.9% YoY) - 2026E: RMB 54,759 million (up 4.7% YoY) - 2027E: RMB 57,498 million (up 5.0% YoY) [2][10] - **Earnings Per Share (EPS)**: - 2023A: RMB 3.00 - 2024A: RMB 2.95 - 2025E: RMB 2.63 - 2026E: RMB 2.76 - 2027E: RMB 2.89 [2][10] - **Key Financial Ratios**: - Return on Equity (ROE): 14.6% in 2023A, declining to 11.9% in 2025E, then recovering to 12.3% in 2027E [2][10]. - Price-to-Earnings Ratio (P/E): 10.4 in 2023A, increasing to 15.9 in 2025E, then stabilizing around 14.5 in 2027E [2][10]. - **Cash Flow**: - Operating cash flow is projected to be RMB 89,687 million in 2023A, decreasing to RMB 82,544 million in 2025E, and recovering to RMB 92,973 million by 2027E [11].

证券研究报告·公司点评报告·非银金融 指南针（300803） 2025 年年报点评：市场活跃+业务协同效应 释放，业绩稳健增长 买入（维持） | [Table_EPS] 盈利预测与估值 | 2024A | 2025A | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 1,529 | 2,146 | 2,898 | 4,083 | 5,602 | | 同比（%） | 37.37% | 40.39% | 35.02% | 40.89% | 37.22% | | 归母净利润（百万元） | 104 | 228 | 264 | 347 | 452 | | 同比（%） | 43.50% | 118.74% | 15.95% | 31.32% | 30.32% | | EPS-最新摊薄（元/股） | 0.17 | 0.37 | 0.43 | 0.57 | 0.74 | | P/E（现价&最新摊薄） | 723.81 | 330.91 | 285.39 | 217.32 | 166.76 | [Table_Tag] [ ...